Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Net Margin (2016 - 2018)

Historic Net Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to 2644.51%.

  • Armata Pharmaceuticals' Net Margin rose 142945100.0% to 2644.51% in Q4 2018 from the same period last year, while for Dec 2018 it was 1469.08%, marking a year-over-year increase of 139873400.0%. This contributed to the annual value of 955.06% for FY2024, which is 32323600.0% up from last year.
  • As of Q4 2018, Armata Pharmaceuticals' Net Margin stood at 2644.51%, which was up 142945100.0% from 529.97% recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Net Margin high stood at 14070.87% for Q3 2014, and its period low was 43181.82% during Q4 2016.
  • In the last 5 years, Armata Pharmaceuticals' Net Margin had a median value of 2484.38% in 2015 and averaged 5994.36%.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 2000000000bps in 2014, then crashed by -406974400bps in 2016.
  • Over the past 5 years, Armata Pharmaceuticals' Net Margin (Quarter) stood at 984.16% in 2014, then tumbled by -152bps to 2484.38% in 2015, then plummeted by -1638bps to 43181.82% in 2016, then skyrocketed by 73bps to 11650.0% in 2017, then soared by 123bps to 2644.51% in 2018.
  • Its last three reported values are 2644.51% in Q4 2018, 529.97% for Q3 2018, and 1085.41% during Q2 2018.